FDA rejects serelaxin for acute heart failure

The Food and Drug Administration has decided that more evidence of serelaxin’s efficacy as a treatment for acute heart failure is needed before the drug can be approved in the United States, Novartis...

Field of Interest: Cardiology
Type: News Item

In obesity and knee OA, weight loss is a big win

PARIS – Weight loss of more than 5% produced clinically meaningful improvements in knee osteoarthritis, even when final body mass index remained high, a large, community-based study has shown. For...

Field of Interest: Rheumatology
Type: News Item

Poor vibratory sense contributes to OA knee instability

PARIS – Impaired vibratory sense and muscle strength may be important risk factors for knee instability in persons with or at risk for symptomatic knee osteoarthritis, according to an analysis of a...

Field of Interest: Rheumatology
Type: News Item

Poor vibratory sense contributes to OA knee instability

PARIS – Impaired vibratory sense and muscle strength may be important risk factors for knee instability in persons with or at risk for symptomatic knee osteoarthritis, according to an analysis of a...

Field of Interest: Geriatrics
Type: News Item

SLGT2 inhibitors show promise in renal protection

LAS VEGAS – In the opinion of Dr. David Cherney, it’s not uncommon for physicians to feel grim about the limited efficacy of available agents to treat chronic kidney disease in patients with type 1...

Field of Interest: Endocrinology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness